CMS GLP-1 obesity coverage pilot raises questions
news.google.com
A new pilot testing coverage for GLP-1 obesity drugs under Medicare has sparked debate over costs, access, and the agency’s understanding of long‑term effects.
Continue reading at news.google.com →
Related Reading
- Democratic candidates revive Medicare for All pitch in battleground states · Washington Times · 38m ago
- Navigating Medicare can be confusing. Here's how New Yorkers can get help · CBS News · 42m ago
- ‘Real Common Ground’: Nursing Homes Support Key LTC Reform Proposals While Seeking Adjustments · Skilled Nursing News · 55m ago
- Navigating the Medicare maze · CBS News · 57m ago
- Skilled Nursing Dealbook: CFG Finances $806M for 36-SNF Acquisition; Dwight Closed $624M in September · Skilled Nursing News · 1h ago
- CMS Will Review Medicare Cost Report Worksheet S-12 · Forvis Mazars US · 2h ago
